Quick Answer
Galmed Pharmaceuticals Ltd. reported Earnings Per Share Diluted of $2.39 per share for the year ending 2025.
- Galmed Pharmaceuticals Ltd. showed a decrease of -70.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Galmed Pharmaceuticals Ltd.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Galmed Pharmaceuticals Ltd.'s Earnings Per Share Diluted has declined by 87.9%.
- Historical annual values: Fiscal year 2025: $2.39 per share | Fiscal year 2024: $8.08 per share | Fiscal year 2023: $30.00 per share | Fiscal year 2022: $127.80 per share | Fiscal year 2021: $19.80 per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: